Tumor Necrosis Factor Blocker class drugs

1 result

Hyrimoz (adalimumab-adaz)

(adalimumab-adaz)
Sandoz Inc
Usage: HYRIMOZ is indicated for treating adult patients with moderate to severe chronic plaque psoriasis who require systemic therapy or phototherapy, and when alternative therapies are unsuitable. Patients must be closely monitored and have regular follow-ups with a physician.